PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.81%
Revenue growth of 1.81% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
23.28%
Gross profit growth of 23.28% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
119.76%
EBIT growth of 119.76% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
119.76%
Operating income growth of 119.76% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
-0.34%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would investigate factors dragging net income down.
5.93%
EPS growth of 5.93% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
7.76%
Diluted EPS growth of 7.76% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-73.67%
Negative OCF growth while Healthcare median is -1.96%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-24.62%
Negative FCF growth while Healthcare median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
729.33%
3Y CAGR of 729.33% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
-5193.14%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-372.30%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-681.49%
Negative 3Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
1634.96%
Net income/share CAGR of 1634.96% while Healthcare median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
2589.28%
Net income/share CAGR of 2589.28% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
428.42%
3Y net income/share CAGR of 428.42% while Healthcare median is zero. Walter Schloss might see a small advantage that can be scaled further.
6077.40%
Equity/share CAGR of 6077.40% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
14361.42%
5Y equity/share CAGR of 14361.42% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
589.54%
3Y equity/share CAGR of 589.54% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.59%
AR growth of 34.59% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
24.96%
Inventory growth of 24.96% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
0.90%
Asset growth of 0.90% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
2.53%
BV/share growth of 2.53% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-1.79%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
135.68%
R&D growth of 135.68% while Healthcare median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
2.34%
SG&A growth of 2.34% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.